August 25th 2020
Elaine Shum, MD, discusses emerging targeted therapies in EGFR-mutant non–small cell lung cancer.
August 4th 2020
Elaine Shum, MD, discusses consulting patients with non-small cell lung cancer on the use of osimertinib.
March 20th 2019
Elaine Shum, MD, medical oncologist, NYU Langone’s Perlmutter Cancer Center, discusses the use of dacomitinib in the treatment of patients with EGFR-positive non–small cell lung cancer.